In today’s COVID-19 environment, more than ever, the myMatrixx team understands how to innovate and adapt to the changing workforce conditions. Our mission, to provide you with the highest level of customized service, has never been more important. We care deeply about our partners and their injured workers, and we are committed to providing you with the comprehensive information and resources you need to make decisions to support and grow your business.
Please use this resource to stay informed on how myMatrixx is addressing COVID-19 and check in often, as this page is updated frequently.
Image
COVID-19 Helpful Resources
Learn what the Coronavirus is, how it started, symptoms, prevention, and more:
COVID-19 Position Paper
myMatrixx View on COVID-19 Vaccination and Workers' Compensation Coverage
Latest Information on the Search for a Safe and Effective Vaccine (COVID-19)
July 01, 2020
As development of a vaccine for COVID-19 continues to be a high a priority in the overall effort to control the pandemic, there are currently over a 100 potential vaccines in development. Although commercial availability of a vaccine is still realistically 12 to 18 months away, the “COVID-19 - Searching...
Learn more
Resources for Returning to the Worksite
June 29, 2020
With government agencies and workplace organizations establishing guidelines for businesses to safely return employees to worksites, myMatrixx will be following the recommendations recently given by our parent company Express Scripts . On the overview page, which can be found here , there are guides...
Learn more
Information and Guidelines for Novel Coronavirus (COVID-19)
June 22, 2020
myMatrixx is closely monitoring the 2019 Novel Coronavirus (COVID-19) and our top priority is the safety and service of our customers, clients, employees and partners. “The spread of the novel coronavirus, COVID-19, is raising concerns around the world. People want to know how to stay safe, how...
Learn more
FDA Update on COVID-19 Treatment
June 16, 2020
Today, the FDA revoked the Emergency Use Authorization (EUA) which allowed for chloroquine and hydroxychloroquine donated to the Strategic National Stockpile (SNS) to be distributed and used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation...
Learn more
myMatrixx President Mike Cirillo Featured in Risk & Insurance Magazine
June 01, 2020
The COVID-19 pandemic has brought rapid changes to the workers’ comp industry, meaning companies across the field have had to develop timely responses under less-than-ideal circumstances. In a new article for Risk & Insurance Magazine, Mike Cirillo , myMatrixx President, spoke extensively...
Learn more
Governors, Lawmakers and Regulators Introducing Workers’ Comp Benefits for Injured Workers
April 24, 2020
myMatrixx parent company, Cigna is seeing a wide range of proposals throughout the states on how to address the impact on COVID-19 on the medical and workers’ compensation system. In the area of workers’ compensation benefits, most efforts today point to enactment of legislation or regulations...
Learn more
MedWatch Update: Warning Issued on COVID-19 Drugs
April 24, 2020
The FDA has issued a warning against the use of hydroxychloroquine and chloroquine for COVID-19 outside a hospital or clinical trial setting due to the increased risk for heart rhythm issues. These medications have not been shown to be safe and effective for treating or preventing COVID-19. Earlier...
Learn more
New York Workers’ Comp Board Extends Formulary Deadline for Prescription Renewals to January 1, 2021
April 15, 2020
Due to the unprecedented health care challenges caused by the COVID-19 pandemic, the New York State Workers’ Compensation Board has extended the deadline for providers to obtain prior authorization for renewals of non-formulary medications. The previous deadline of June 5, 2020, has now been moved...
Learn more